Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu-Yuan Li

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|July 27, 2012
TNFSF15 Modulates Neovascularization and InflammationZhisong Zhang, Lu-Yuan Li
Cancer Research|January 13, 2011
The first Tianjin, China forum on tumor microenvironmentEvan T Keller, Lu-Yuan Li
Signal Transduction and Targeted Therapy|August 14, 2018
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15Gui-Li Yang, Lu-Yuan Li
Cell Research|December 16, 2003
The enigmatic role of angiopoietin-1 in tumor angiogenesisLinda J Metheny-Barlow, Lu Yuan Li
Apoptosis : an International Journal on Programmed Cell Death|May 7, 2009
Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-kappaB pathwaySammy Grimaldo, Fang Tian, Lu-Yuan Li
Seminars in Ophthalmology|March 7, 2006
Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesisLinda J Metheny-Barlow, Lu-Yuan Li
Blood|March 31, 2009
Inhibition of endothelial progenitor cell differentiation by VEGIFang Tian, Paulina H Liang, Lu-Yuan Li
Pediatric Endocrinology Reviews : PER|January 24, 2006
Angiopoietins and Tie2 in health and diseaseLu-Yuan Li, Keith D Barlow, Linda J Metheny-Barlow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growthWen Hou, Dan Medynski, Shirley Wu, et al.
Microvascular Research|October 27, 2004
Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGFLinda J Metheny-Barlow, Song Tian, Andrew J Hayes, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|July 27, 2012
TNFSF15 Modulates Neovascularization and InflammationZhisong Zhang, Lu-Yuan Li
Cancer Research|January 13, 2011
The first Tianjin, China forum on tumor microenvironmentEvan T Keller, Lu-Yuan Li
Signal Transduction and Targeted Therapy|August 14, 2018
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15Gui-Li Yang, Lu-Yuan Li
Cell Research|December 16, 2003
The enigmatic role of angiopoietin-1 in tumor angiogenesisLinda J Metheny-Barlow, Lu Yuan Li
Apoptosis : an International Journal on Programmed Cell Death|May 7, 2009
Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-kappaB pathwaySammy Grimaldo, Fang Tian, Lu-Yuan Li
Seminars in Ophthalmology|March 7, 2006
Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesisLinda J Metheny-Barlow, Lu-Yuan Li
Blood|March 31, 2009
Inhibition of endothelial progenitor cell differentiation by VEGIFang Tian, Paulina H Liang, Lu-Yuan Li
Pediatric Endocrinology Reviews : PER|January 24, 2006
Angiopoietins and Tie2 in health and diseaseLu-Yuan Li, Keith D Barlow, Linda J Metheny-Barlow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growthWen Hou, Dan Medynski, Shirley Wu, et al.
Microvascular Research|October 27, 2004
Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGFLinda J Metheny-Barlow, Song Tian, Andrew J Hayes, et al.
Pageof 6